Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.
about
Patient and provider characteristics associated with the decision of HIV coinfected patients to start hepatitis C treatment.Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis.Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs.Factors that influence an HIV coinfected patient's decision to start hepatitis C treatmentFormal patient education improves patient knowledge of hepatitis C in vulnerable populationsAssessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection.Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perceptionHepatitis C Virus Disease Progression in People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis.Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals.A multidimensional education program at substance dependence treatment centers improves patient knowledge and hepatitis C care.Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment.Perceptions of drug users regarding hepatitis C screening and care: a qualitative studyReasons for Nonattendance across the Hepatitis C Disease Course.HCV knowledge among a sample of HCV positive Aboriginal Australians residing in New South Wales.Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia.Health Beliefs and Co-morbidities Associated with Appointment-Keeping Behavior Among HCV and HIV/HCV Patients.Health workers' support for hepatitis C treatment uptake among clients with a history of injecting.Perceived benefits of the hepatitis C peer educators: a qualitative investigation.Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study.Attitudes of regular injecting drug users towards the legal status of the major illicit drugs.Reducing barriers to hepatitis C treatment among drug users: an integrated hepatitis C peer education and support program.A randomized trial of a hepatitis care coordination model in methadone maintenance treatment.
P2860
Q30405780-32D8E29D-A139-42B1-9C2F-65ED7356550CQ30406126-A2EC8631-209C-4E46-B1E5-D3D1DAD4D6E5Q30873859-DAD24E12-2F76-4EBD-B819-36FA1628E7F1Q33705645-9A20139F-7A41-4652-9DBB-1BCCA6EFEC73Q34435133-DF72A9D6-0E97-4762-8844-1A3A1376AFE8Q34736149-6D5DF641-7569-4B72-95EE-2D0A4A971DB5Q35634124-BFD1C423-E784-409C-B12B-8DF4FF1C52ABQ35770129-A976102A-4692-465B-AA0A-016193E7E36FQ35922263-B1B1FF60-A5AA-4DAA-85FA-7DD84F78E292Q36137527-8EE375C0-2489-4DA9-9611-665DD91D71A9Q36161813-7D8AB6CE-5B61-44EC-97D1-3AFD932D085EQ36595579-E29B0B21-659A-4BDD-B5B7-E91B996D0956Q36964408-27604238-A7CA-49F1-BCED-AC2D03284B31Q37206303-C7854BFF-F6D7-4FB8-B42E-B0E0AECC61D9Q38857464-D7857805-1B1D-448C-9E9D-44FE9D0CAC29Q39918668-21EDAA92-69E2-4107-987D-26A1E2DAE104Q40144817-C91831C7-BFAF-434B-B301-8946F29FCED6Q40732010-A5769324-2891-487E-84B2-1F42F4A560EBQ40789247-05CEAADA-A4CC-4950-AFE0-D0F065F62190Q41942103-4A30DD15-290A-4F0A-9813-24678D8B9E51Q42251464-7AB61A83-C3B8-4B56-9ADC-D7FDC6D1697AQ43512937-9BD3C118-B4E4-4285-9190-F2825CE09930Q51831518-41BF02E7-70C8-4076-962E-B23A949E6061Q51867806-FC5B1C2C-80D8-490A-8A5B-9E0655B4DC64
P2860
Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exploring drug users' attitude ...... C (HCV) treatment in the U.S.
@en
Exploring drug users' attitudes and decisions regarding hepatitis C
@nl
type
label
Exploring drug users' attitude ...... C (HCV) treatment in the U.S.
@en
Exploring drug users' attitudes and decisions regarding hepatitis C
@nl
prefLabel
Exploring drug users' attitude ...... C (HCV) treatment in the U.S.
@en
Exploring drug users' attitudes and decisions regarding hepatitis C
@nl
P2093
P2860
P1476
Exploring drug users' attitude ...... C (HCV) treatment in the U.S.
@en
P2093
Andrew Osborne
Andrew Rosenblum
Corrine E Munoz-Plaza
Don Des Jarlais
Janetta Astone-Twerell
Marya Gwadz
Shiela Strauss
P2860
P356
10.1016/J.DRUGPO.2007.02.003
P50
P577
2007-08-06T00:00:00Z